AmnioLife: AmnioLife To Launch Human DBM Product Line In Q4 2015

GAINESVILLE, Fla., Sept. 24, 2015 (GLOBE NEWSWIRE) -- AmnioLife Corporation, a human cells, tissues, and cellular and tissue-based products developer, today announced it has successfully completed sterilization validation testing using electron beam sterilization technology on its human demineralized bone matrix (DBM) allograft product line, Oncor, for both U.S. and international commercialization...